This compound is a protected derivative of D-glutamic acid, featuring an Fmoc group for temporary amine protection and tert-butyl ester groups for side-chain carboxyl protection. It is primarily employed as a building block in solid-phase peptide synthesis to introduce the D-glutamic acid residue.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 104091-08-9
(S)-2-Fmoc-aminohexanedioic acid 6-tert-butyl ester
pharmaceutical intermediate
Fmoc-Glu(OtBu)-Phe-OH
pharmaceutical intermediate
N-(tert-Butoxycarbonyl)-D-lysine
pharmaceutical intermediate
N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE
pharmaceutical intermediate
N-(benzyloxycarbonyl)aspartic acid
pharmaceutical intermediate
(S)-22-(tert-Butoxycarbonyl)-45,45-dimethyl-10,19,24,43-tetraoxo-3,6,12,15,44-pentaoxa-9,18,23-triazahexatetracontanoic acid
pharmaceutical intermediate
L-3,5-diiodothyronine
pharmaceutical intermediate
Tert-Butyl 2,6-diazaspiro[3,3]heptane-2-carboxylate hemioxalate
pharmaceutical intermediate
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid
OTKXCALUHMPIGM-HXUWFJFHSA-N
CC(C)(C)OC(=O)CC[C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13